Logo Image
News
All News
Publications
All PublicationsPharmTechPharmTech Europe
Multimedia
All VideosAsk the ExpertBehind The HeadlinesDrug Digest VideosDrug Solutions PodcastShorts
Conferences
Conference CoverageConference Listing
More
Webcasts
Resources
ICH Q9 Revision: A Comprehensive Resource on Quality Risk ManagementPartnersPeer-Reviewed ResearchPharmTech ProductsPharma InsightsSponsored PodcastsSponsored VideosSponsored eBooksState of the ScienceWhitepapers
Event Calendar

Subscribe

  • News
  • Publications
  • Multimedia
  • Conferences
  • Webcasts
  • Resources
  • Event Calendar
  • Subscribe
  • Analytics
    • Bio/Pharmaceutical Analysis Techniques
    • Laboratory Equipment and Instruments
  • Data and Artificial Intelligence
  • Dosage Forms
    • Solid/Semi-Solid Dosage
    • Specialty Dosage Drugs
    • Parenterals and Injectables
    • Inhalation Drugs
  • Drug Development
    • Intellectual Property and Patents
    • Process and Scaling
    • APIs and Excipients
    • Ingredients
    • Formulation and Drug Delivery
  • Manufacturing
    • Aseptic/Sterile Processing
    • Equipment
    • Process and Automation
    • Manufacturing, Parenterals and Injectables
    • Manufacturing, Biosimilars and Biobetters
    • Manufacturing, Inhalation Drugs
    • Manufacturing, Solid and Semi-Solid Dosage Drugs
    • Manufacturing, Cell Therapies
    • Manufacturing, Biologic Drugs
    • Supply Chain
    • Manufacturing, Gene Therapies
    • Packaging and Distribution
  • Outsourcing
    • Contract Research Services
    • Contract Analytical Services
    • Contract Development Services
    • Regulatory Consulting
    • Logistics and Distribution
    • Contract Manufacturing Services
  • Quality Systems
    • Ask the Expert
    • Quality Assurance/Quality Control
    • Regulatory Oversight and Compliance
Spotlight -
Analytics|
Dosage Forms|
Drug Development|
Manufacturing|
Outsourcing|
Quality Systems
Advertisement
|Articles|October 26, 2004

ITF-Levoxyl

Author(s)Pharmaceutical Technology Editors

Pharmaceutical science and technology news

Advertisement
External Link - article-130642.pdf

Advertisement
PharmTech News

Related Content

Advertisement
GSK to build a new facility at the Cambridge Biomedical Campus

GSK Cambridge Move Signals Shift in Drug Scale-Up Strategy

ByZachary Zubulake
July 28th 2026

FDA's Manufacturing Registration Rule's Impact on Advanced Therapies: Part 1

ByJason Bock
July 28th 2026

Technology Transfer Between Contractors, A Panel Discussion, Part 2

ByKaty MacLellan,Lauren Nolan,Yash Sabharwal,Judyta Suskiewicz
July 28th 2026
2026 Midyear Check-in

Midyear 2026 Industry Report: Taking Stock of Pharma Manufacturing, AI, and Regulatory Trends

ByCampbell Bunce,Mike Stenberg,Saharsh Davuluri,Manish Garg, PMP, PSM,Megha Sinha,Henrik Johanning,Remco Munnik,Christopher Cole
July 27th 2026
Chronic obstructive pulmonary disease, respiratory diseases, 3d illustration | Image Credit: ©Crystal light -stock.adobe.com

European Biotechs Reshaping Respiratory Disease

ByCheryl Barton
July 27th 2026
Advertisement
Advertisement

Trending on Pharmaceutical Technology

1

European Biotechs Reshaping Respiratory Disease

2

Midyear 2026 Industry Report: Taking Stock of Pharma Manufacturing, AI, and Regulatory Trends

3

Six Months In: A 2026 Progress Check on Pharma Manufacturing, AI, and Regulatory Shifts

4

Q&A: Pharma AI in 2026: Discovery Solved, Execution Still Manual

5

Technology Transfer Between Contractors, A Panel Discussion, Part 1

  • About Us
  • Advertise
  • Contact Us
  • Editorial Info
  • Editorial Advisory Board
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us